Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

FDA Issues Emergency Use Authorization for Drugs to Prevent and Treat New World ...

3 September 2026 · By · Wire by Fusion42

Published

3 September 2026

Topic

opportunities

◆ Sectors

Health

◆ Geography

United States

◆ Source

Read at fda.gov →

◆ Verified

Fusion42 · 4 September 2026 · Fusion42 review

The FDA granted Emergency Use Authorization for Capstar and its generic Nitenpyram Tablets to prevent and treat New World screwworm infestations in dogs and cats, expanding their use from treatment only to prevention as well.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

You now have an FDA-approved preventative drug for New World screwworm in pets, opening new opportunities in veterinary care and pet health products. This authorization means faster market entry if your startup addresses vet treatments or diagnostics in affected regions.

◆ Coverage

1 source · 3 Sep 2026

◆ Related on Wire

◆ Topics

Healthfdaemergency-use-authorizationveterinary-drugsanimal-healthnew-world-screwworm